Medical Writing for Pharma, Healthcare and Medical Devices
Medical Writing translates medical and scientific evidence into precise content for healthcare professionals and other stakeholders in healthcare. As a Medical Writing agency, co.medical supports pharmaceutical and healthcare companies as well as medical device manufacturers with scientific publications, the communication of clinical study data and medical-scientific materials.
Our Medical Writers combine medical and scientific expertise with strong writing skills and an understanding of different communication objectives and channels. The team has experience across numerous therapeutic areas and develops medical content in both English and German.
Medical Writing Services for Pharma and Healthcare
Our Medical Writing services for pharmaceutical companies cover Scientific and Publication Writing, the communication of clinical study data and medical-scientific content for Medical Affairs and healthcare professionals.
-
Scientific & Publication Writing: original articles, reviews, abstracts, posters and other scientific publications
-
Medical Writing for clinical studies: preparation of clinical study data for Clinical Study Reports and scientific communication
-
Medical Affairs & HCP Content: slide decks, training materials, product brochures, congress communication and other materials for Medical Affairs and healthcare professionals
-
Medical Content: medical-scientific content for websites, mailings and other digital and print communication channels
Medical Writing for Healthcare Professionals
Medical communication for healthcare professionals must be scientifically precise while clearly conveying the clinical relevance of the content. Our Medical Writers develop content for physicians, pharmacists and other healthcare professionals based on clinical study data, scientific literature and other sources of evidence.
Depending on the communication objective, this may include scientific publications, reviews, medical presentations, training materials, product brochures, congress reports or digital content. We also prepare complex bodies of evidence in a way that communicates the key scientific messages clearly and transparently.
Medical Writing Services for Healthcare Professionals
-
Original articles: prepare clinical study data for publication in medical journals
-
Reviews and review articles: research, structure and contextualize scientific evidence within the clinical setting
-
Abstracts and posters: summarize study results precisely for scientific congresses
-
Medical Affairs Content: develop scientific presentations, slide decks and training materials
-
HCP Content: create scientifically sound product brochures, folders, visual aids, mailings and web content
-
Congress communication: structure and summarize relevant scientific findings from congresses
-
Advisory Board Documentation: document discussions and outcomes from Advisory Board meetings
Medical Content for Pharma and Healthcare
Medical Content translates scientific evidence into audience-specific content for healthcare professionals and other stakeholders. co.medical develops Medical Content for websites, mailings, product brochures, presentations and digital communication formats, among others.
Medical Writing for Clinical Studies
Clinical study data form the basis for numerous scientific and medical communication formats. Our Medical Writers structure complex study results and prepare them according to the respective purpose and target audience.
Clinical Study Reports
Clinical Study Reports (CSRs) document the methodology and results of clinical studies in a structured format. co.medical supports the preparation, revision and quality assurance of Clinical Study Reports as well as the consistent presentation of clinical study data.
Publication of Clinical Study Data
For scientific publication, study data are prepared according to the requirements of the respective format. Our Medical Writers support the development of manuscripts, abstracts, posters and scientific presentations and accompany projects from structuring the results through to the final version.
Scientific Publications Supported by co.medical Medical Writers
Our medical writers support authors and companies with scientific publications, from structuring the content and preparing the data through to a publication-ready manuscript.
Selected Scientific Publications Supported by Our Team
- Sperk E, Lemanski C, Neumaier C et al. BMC Cancer 2025. DOI: 10.1186/s12885-025-15289-0 https://link.springer.com/article/10.1186/s12885-025-15289-0
- Gillissen A, Reineke T, Burkart M et al. Frontiers in Pharmacology 2025. DOI: 10.3389/fphar.2025.1652203 https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2025.1652203/full
- Rahbar K, Giesel FL, Herrmann K et al. Journal of Nuclear Medicine 2025. https://jnm.snmjournals.org/content/early/2025/10/23/jnumed.125.269818.long
- Packbiers M, Hahm A, Riebeling T et al. Journal of Nephrology 2025. DOI: 10.1007/s40620-025-02405-3. https://link.springer.com/article/10.1007/s40620-025-02405-3#citeas
- Herold J, Dagkonakis N, Debus ES et al. European Journal of Vascular Medicine 2025. DOI: 10.3238/arztebl.m2024.0257 https://econtent.hogrefe.com/doi/10.1024/0301-1526/a001174
- Zeymer U, Bauersachs RM, Dagkonakis N et al. Clin Res Cardiol. 2025. DOI: 10.1007/s00392-025-02603-w https://link.springer.com/article/10.1007/s00392-025-02603-w#citeas
- Farschtschi S, Vaassen P, Kluwe L et al. Dtsch Arztebl Int 2025. DOI: 10.3238/arztebl.m2024.0257 https://www.aerzteblatt.de/archiv/altersadaptierte-diagnose-und-versorgung-der-neurofibromatose-typ-1-a1858faa-8c53-4f0f-a9a2-e18533e64e48?tabId=authors
- Bohlken J, Hajek, A, Burkart M, Kostev, K et al. Brain Sci. 2025. https://doi.org/10.3390/brainsci15010012 https://www.mdpi.com/2076-3425/15/1/12
- Neubauer C, Kragl M, Braun T et al. European Journal of Dermatology 2024. DOI: 10.1684/ejd.2024.4738. View publication
- Goebell PJ, Cornelius F, Fernandez Milano A et al. Die Urologie 2023. DOI: 10.1007/s00120-024-02434-z View publication
- Schaefers C, Miething C, Salwender H et al. Journal Onkologie 2024. View publication
- Goetze TO, Roderburg C, Friedrich FW, Trojan J. ESMO Gastrointestinal Oncology 2024. DOI: 10.1016/j.esmogo.2024.100092. View publication
- Endrikat J, Gutberlet M, Barkhausen J, et al. Investigative Radiology 2023. DOI: 10.1097/RLI.0000000000001041 View publication
- van Bömmel F, Berg T, und Lordick F. ESMO Gastrointestinal Oncology 2023. DOI: 10.1016/j.esmogo.2023.08.004 View publication
- Bittner CB, Steindl H, Abramov-Sommariva D et al. Postgraduate Medicine 2023. DOI: 10.1080/00325481.2023.2234274 View publication
- Szeimies RM, Abels C, Kilic A et al. J Eur Acad Dermatol Venereol. 2023. DOI: 10.1111/jdv.18843 View publication
- Endrikat J, Khater H, Boreham ADP et al. Breast Cancer: Basic and Clinical Research 2023. DOI: 10.1177/11782234231189467 View publication
- Schnuchel A, Radcke C, Theobald L et al. PLOS ONE 2023. DOI: 10.1371/journal.pone.0285948 View publication
- Wohlrab J, Bechara FG, Schick C et al. Dermatology and Therapy 2023. DOI: 10.1007/s13555-022-00885-w View publication
- Nausch B, Bittner CB, Höller M et al. Antibiotics 2022. DOI: 10.3390/antibiotics11101331 View publication
- Doehn C, Bögemann M, Grünwald V et al. Cancers 2022. DOI: 10.3390/cancers14225486 View publication
- Tanaka Y, Okudab K, Takeuchic Y et al. Modern Rheumatology 2022. DOI: 10.1093/mr/roac103 View publication
- Wang Y, Chen Y, Liu P et al. European Radiology 2022. DOI: 10.1007/s00330-021-08505-5 View publication
- Boreham A. Nova Acta Leopoldina 2021; 423:211–217 View publication
- Abels C, Soeberdt M, Kilic A et al. Br J Dermatol. 2021. DOI: 10.1111/bjd.19810 View publication
- Pellegrin M, Rohrhofer A, Schuster P et al. Clinical Phytoscience 2021. DOI: 10.1186/s40816-021-00264-6 View publication
- Kardos P, Bittner C, Seib J et al. Current Medical Research and Opinion 2021. DOI: 10.1080/03007995.2021.1960493 View publication
- Diebold R, Schopf B, Stammer H et al. Arch Gynecol Obstet 2021. DOI: 10.1007/s00404-021-06040-8 View publication
- Todenhöfer T, Maas M, Ketz M et al. World J Urol 2021. DOI: 10.1007/s00345-020-03587-0 View publication
- Völker J, Koch N, Becker M, Klenk A. Skin Pharmacol Physiol 2020; 33:153–169. View publication
- Soeberdt M, Kilic A, Abels C. European Journal of Pharmacology 2020. DOI: 10.1016/j.ejphar.2020.173242 View publication
- Chabicovsky M, Winkler S, Soeberdt M et al. Toxicology and Applied Pharmacology 2019; 370:154–169 View publication
- Kilic A, Masur C, Reich H et al. J Dermatol 2019; 46:457–465 View publication
- Stöver H, Jamin D, Michels II et al. Harm Reduction Journal 2019. DOI: 10.1186/s12954-019-0340-4 View publication
- Rengo M, Dharampal A, Lubbers M et al. European Radiology 2019. DOI: 10.1007/s00330-019-06196-7 View publication
- Chatsiproios D, Schmidts-Winkler I-M, König L et al. PLOS ONE 2019; 14(1): e0210967. View publication
- Kilic A, Harder A, Reich H et al. Clinical, Cosmetic and Investigational Dermatology 2018:11 591–602 View publication
- Angelova-Fischer I, Fischer T, Abels C et al. Br J Dermatol. 2018; 179:471-477. View publication
- Baumueller M, Rau S. J Phlebol Lymphol. 2018;11(1):7-12. View publication
- Oláh A, Szabó-Papp J, Soeberdt M et al. J Dermatol Sci. 2017; 88(1):67-77. View publication
- Kucharzik T, Lemmnitz G, Abels C et al. Inflammatory Bowel Diseases 2017; 23(2):261-271. View publication
- Schmidt T, Brumme U, Rauner K. DGGÖ Congress, Berlin 2016; March 13–15.
- Hahn M, Böer B, Marx M et al. Senologie 2016; 13(1):20-22. View publication
- Branco JC, Barcelos A, De Araujo FP et al. Advances in Therapy 2016; 33(1):46-57. View publication
- Tschöpe C, Kherad B, Spillmann F et al. Herz 2016; 41(8):697-705. View publication
- Merseburger AS, Sedding D, Huter K. Der Urologe. 2016; 55(2):218-225. View publication
- Raab M, Schöhl M, Ikenberg I. Current Real-World Treatment of Multiple Myeloma in Germany. DGHO Annual Meeting, Basel 2015; October 9–13.
- Danhof S, Schreder M, Strifler S et al. Case Reports in Oncology 2015; 8(1):189-195. View publication
- Kemper M, Bielfeldt K, Knie U et al. Cosmetics 2015; 2:136-145. View publication
- Wolff JM, Schmid HP. Der Urologe. 2015; 54(11):1578-1583. View publication
- Verheggen BG, Westerhout KY, Schreder CH et al. Clinical and Translational Allergy 2015; 5:1. View publication
- Kurbacher CM, Fietz T, Diel IJ et al. Oncology Research and Treatment 2015; 38(5):221-229. View publication
- Hofheinz RD, Arnold D, Kubicka S et al. Oncology Research and Treatment 2015; 38(6):300-308. View publication
- Schulze M, Stiegler H, Thielecke C et al. Der Urologe. 2014; 53(6):865-870. View publication
- Oettle H. Cancer Treatment Reviews 2014; 40(9):1039-1047. View publication
- Oettle H. Journal of Cancer Therapy 2013; 4:13-27.
- Merseburger AS, Kuczyk MA, Wolff JM. Der Urologe. 2013; 52(2):219-225. View publication
- Heinemann V, Di Gioia D, Vehling-Kaiser U et al. Annals of Oncology 2011; 22(3):603-608. View publication
How Our Medical Writing Agency Works
co.medical is a Medical Writing agency for pharmaceutical, healthcare and medical device companies. Our Medical Writers combine medical and scientific expertise with experience in publications, clinical study data, Medical Affairs and HCP communication.
A Medical Writing project starts with the communication objective, target audience and scientific evidence. Based on these elements, our Medical Writers structure the content, develop the text and support scientific review and approval processes through to the final version.
1. Briefing and objectives: Define the target audience, communication objective, format and scientific basis.
2. Structure the evidence: Analyze and prepare study data, literature and existing medical materials.
3. Develop the content: Formulate scientific content precisely and in line with the intended communication channel.
4. Scientific Review: Integrate scientific comments in a structured manner and align the content with authors, Medical Affairs and other stakeholders.
5. Finalization: Finalize text, references and format for publication, approval or further production.
Frequently Asked Questions about Medical Writing
What does Medical Writing for pharmaceutical companies include?
Medical Writing for pharmaceutical companies includes the scientifically sound preparation of medical and clinical information for different communication formats. This includes scientific publications, Clinical Study Reports, abstracts and posters as well as Medical Affairs and HCP materials.
What does Medical Writing for clinical studies include?
Medical Writing for clinical studies includes the structured preparation of study design, methodology and results for scientific and medical documents. co.medical supports the development of Clinical Study Reports as well as manuscripts, abstracts, posters and presentations based on clinical study data.
Does co.medical provide Medical Writing in English and German?
Yes. co.medical develops medical-scientific content in English and German. Language, level of detail and format are adapted to the target audience, communication objective and intended channel.